Piramal Enterprises on Tuesday said its board approved raising of up to Rs 650 crore by issuing non-convertible debentures. The size of the issue is up to Rs 50 crore with an option to retain over subscription of up to Rs 600 crore, according to a regulatory filing.
Bengaluru (Karnataka) [India], Jan 6 (ANI): Biopharmaceuticals major Biocon said on Monday the board of its subsidiary Biocon Biologics has approved a primary equity investment by True North which will invest Rs 536.25 crore to pick 2.44 per cent minority stake in the biosimilars business.